Welcome to the ISIS pharmaceuticals Discussion Forum On AGORACOM

Click edit to view fast facts

Free
AGORACOM NEWS FLASH

NEW LISTING ALERT!!!

Awakn Life Sciences to Commence Trading on the NEO Exchange Under the Symbol 'AWKN'

  • Strategic focus on developing and delivering psychedelic medicines to treat Addiction.
  • Strong psychedelic drug development pipeline targeting Addiction.
  • First mover advantage for clinics in the UK and the EU with 400m people and CAD$25TR GDP.
  • The leading research and clinical team in the industry focused on using psychedelics to treat Addiction.
  • Multiple scalable revenue streams across drug development and clinical delivery.

Awakn logoset 300x100

Hub On AGORACOM / Corporate Profile / Recent Interview

 

 

isis pharmaceuticals Stock Quotes

For access to level II stock quotes, you must have attained an Agoracom ranking of at least Treasurer.